Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
The current Amgen(AMGN) stock price is $328.23, with a market capitalization of 177.14B. The stock trades at a price-to-earnings (P/E) ratio of 24.34 and offers a dividend yield of 2.8%.
On 2026-05-01, Amgen(AMGN) stock traded between a low of $324.63 and a high of $346.25. Shares are currently priced at $328.23, which is +1.1% above the low and -5.2% below the high.
The Amgen(AMGN)'s current trading volume is 2.35M, compared to an average daily volume of 2.54M.
During the past year, Amgen(AMGN) stock moved between $261.43 at its lowest and $391.29 at its peak.
During the past year, Amgen(AMGN) stock moved between $261.43 at its lowest and $391.29 at its peak.
AMGN News
Key Points The S&P 500 and Nasdaq 100 hit fresh records Friday morning; the Dow turned negative by midday. Apple's 4.5% post-earnings jump is carrying the tec...
Goldman Sachs analyst Salveen Richter maintained a Buy rating on Amgen today and set a price target of $425.00. Unlock hedge fund-level data and powerful inves...
In early trading on Friday, shares of Datadog topped the list of the day's best performing components of the Nasdaq 100 index, trading up 5.1%. Year to date, Da...
Analyst ratings
51%
of 37 ratingsMore AMGN News
In early trading on Wednesday, shares of Apple topped the list of the day's best performing Dow Jones Industrial Average components, trading up 0.6%. Year to da...
BofA raised the firm’s price target on Amgen (AMGN) to $307 from $304 and keeps an Underperform rating on the shares. The firm, which adjusted estimates in-line...
Image source: The Motley Fool. Thursday, April 30, 2026 at 4:30 p.m. ET Call participants Chairman & Chief Executive Officer — Robert A. Bradway Executive Vice...
Amgen’s product sales were up 4%, led by 9% growth in product volume. Clodagh Kilcoyne / Reuters Amgen AMGN 2.43 %increase; green up pointing triangle said its...
16:03 EDT Amgen (AMGN) sees FY26 CapEx $2.6B; share repurchases not to exceed $3B Published first on TheFly – the ultimate source for real-time, market-moving...
Technology Amgen's Numbers Are Out: It Gets To Keep Its Cholesterol Crown — For Now Licensing Amgen (AMGN) widely beat the Street's first-quarter expectations l...
The FDA's Center for Drug Evaluation and Research has proposed that Amgen withdraw its drug Tavneos, citing untrue statements of material facts and possible dat...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.